References
1. Jacobs MF, Anderson B, Opipari VP, Mody R. Hepatosplenic αβ T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia. Journal of Pediatric Hematology/Oncology. 2020.
2. Shenhod E, Benzeev B, Sarouk I, Heimer G, Nissenkorn A. Functional parameter measurements in children with ataxia telangiectasia. Developmental Medicine & Child Neurology. 2020;62(2):207-13.
3. Mathew MG. Management of a pediatric patient with ataxia telangiectasia: Report of a rare case in which diagnostic radiographs are contraindicated. Journal of Family Medicine and Primary Care. 2020;9(2):1199.
4. Perlman S. Functionally meaningful rating scales in progressive pediatric movement disorders. Wiley Online Library; 2020.
5. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari S-R, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatric neurology. 2007;37(1):21-8.
6. Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, et al. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Immunological Investigations. 2020:1-15.
7. Xu P, Sun Y, Song Y, Jiao J, Shen B, Li W, et al. ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells. Medical Molecular Morphology. 2020:1-11.
8. Tatfi M, Hermine O, Suarez F. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle? Frontiers in immunology. 2019;9:3060.
9. Sarkar A, Stellrecht CM, Vangapandu HV, Ayres M, Kaipparettu BA, Park JH, et al. Ataxia telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica. 2020.
10. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007 Jul;37(1):21-8.
11. Zaki-Dizaji M, Tajdini M, Kiaee F, Shojaaldini H, Badv RS, Abolhassani H, et al. Dystonia in Ataxia Telangiectasia: A Case Report with Novel Mutations. Oman Medical Journal. 2020;35(1):e93.
12. Langhagen T, Blaschek A, Rettinger N, Müller-Felber W, Jahn K. Case report: oculomotor apraxia in ataxia telangiectasia. Neuropediatrics. 2013;44(02):VS12-02.
13. Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Nemati H. Clinical Presentation of Ataxia-Telangiectasia. Archives of Iranian Medicine (AIM). 2019;22(12).
14. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet journal of rare diseases. 2016;11(1):159.
15. Yang Y, Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. Journal of Neuroscience. 2005;25(10):2522-9.
16. Chenevix-Trench G, Spurdle A, Terry MB, Daly M, Buys S, Southey M, et al. Rare variants in the ATM gene and risk of breast cancer. 2011.